Anti-estrogen medication ‘cuts risk of dying from lung cancer’
January 24th, 2011 - 3:22 pm ICT by ANIWashington, Jan 24 (ANI): Tamoxifen, an anti-estrogen breast cancer medication, may reduce an individual’s risk of death from lung cancer, says a new study.
The research supports the hypothesis that there is a hormonal influence on lung cancer and that estrogen levels play a role in lung cancer patients’ prognosis.
Led by Elisabetta Rapiti of the Geneva Cancer Registry, the study compared lung cancer incidence and mortality among breast cancer patients who were and were not treated with anti-estrogen therapy.
The study included all 6,655 women diagnosed with breast cancer between 1980 and 2003 and registered at the Geneva Cancer Registry.
Among these women, 46 percent received anti-estrogens. All women were followed for occurrence and death from lung cancer until December 2007.
The investigators found that 40 women in the study developed lung cancer.
Incidences of lung cancer was not significantly different between breast cancer patients who were and were not treated with anti-estrogens compared with the general population; however, fewer women taking anti-estrogens died from lung cancer than expected.
Specifically, there were 87 percent fewer cases of death due to lung cancer in the anti-estrogen group than in the general population.
The study has been published online in Cancer, a peer-reviewed journal of the American Cancer Society. (ANI)
- Breast cancer drug may reduce risk of death from lung cancer - Dec 12, 2009
- Soy food safe for breast cancer survivors - Apr 06, 2011
- Taking tamoxifen to prevent breast cancer can save lives and cut medical costs - Mar 14, 2011
- Possible clues to tamoxifen resistance in breast cancer patients found - Mar 31, 2011
- New potential target for breast cancer therapy identified - Dec 23, 2010
- Preventive use of breast cancer drugs urged - Mar 28, 2011
- Oestrogen therapy 'causes ovarian cancer to grow five times faster' - Oct 21, 2010
- Low incomes leads to higher mortality rate among prostate cancer patients - Sep 28, 2009
- Drug counters bone-damaging effects of breast cancer medication - Oct 10, 2011
- Worrying about breast cancer returning can hit women's quality of life - Mar 28, 2011
- Long-term tamoxifen use may up aggressive breast cancer risk - Aug 26, 2009
- Soy food lowers breast cancer recurrence, death risk - Dec 09, 2009
- High soy intake reduces risk of breast cancer - Jun 15, 2010
- Key to get estrogen's benefits without cancer risk found - Jun 24, 2010
- Majority of breast cancer patients take antioxidants despite likely risk - Jun 08, 2009
Tags: american cancer society, anti estrogens, breast cancer, breast cancer patients, cancer medication, cancer registry, estrogen levels, geneva, hypothesis, incidences, investigators, jan 24, lung cancer, lung cancer incidence, lung cancer patients, mortality, occurrence, peer reviewed journal, prognosis, tamoxifen